Cognizant (CTSH) Unveils Artificial Intelligence Lab
Get Alerts CTSH Hot Sheet
Join SI Premium – FREE
Cognizant (Nasdaq: CTSH), a leading global technology company, today announced the launch of an Advanced Artificial Intelligence (AI) Lab. The lab, based in
The launch of Cognizant's Advanced AI Lab comes at a time when enterprises are rapidly working to understand the impact of AI and meet expanding expectations around its promise. Recent research has shown more than half (66 percent) of executives are ambivalent or dissatisfied with their company's progress on AI and gen AI, and most executives (85 percent) plan to increase spending on AI and gen AI in 2024. Longer term, Cognizant and Oxford Economics' recent study found gen AI could inject up to
"As AI rapidly evolves into mainstream use, Cognizant is continually pushing boundaries through strategic partnerships, training programs and platform investments to be an AI-first company," said Cognizant CEO Ravi Kumar S. "With the launch of Cognizant's Advanced AI Lab, we're progressing this effort by investing in state-of-the-art core AI research that establishes our position at the forefront of innovation and our industry. Because we own the client solutioning relationship from end to end, we have a unique line of sight into businesses, industries, and their AI needs. We're putting dedicated focus on AI research and development to lay the groundwork for better business outcomes and a better future."
By harnessing the power of Large Language Models (LLMs) as capable knowledge workers, the lab's researchers and developers will use the Cognizant Neuro™ AI platform to orchestrate LLMs into decision-making AI systems that can positively impact and optimize business outcomes. Moving beyond simple prompt engineering and fine-tuning, these customized AI applications will be designed to support higher value outcomes -- from strategic board-level business decisions to enterprise operations including financial, sales, product, and IT support, to day-to-day productivity of individual employees.
"Cognizant's Advanced AI Lab is an important partner for us in the research community, and we've been fast at work with them already working on simulating brain dynamics in healthy and patient populations," said Dr.
Specifically, Cognizant's Advanced AI Lab will focus on the following areas:
- Researching, designing, evaluating, building, and showcasing innovative AI solutions for business productivity and decision making across various domains
- Collaborating with external stakeholders, including research institutions, customers, and startups, and engaging in AI-for-good research projects
- Evangelizing gen AI-enabled decision-making solutions globally, and strengthening Cognizant as a knowledge hub for published, peer-reviewed research on AI
- Partnering across Cognizant's business lines and practices to train and upskill associates on new AI solutions as they become available through the Cognizant Neuro™ AI platform
- Fostering an environment of continuous learning, innovation, and knowledge sharing
The lab will be led by AI entrepreneur and inventor,
In addition to the launch of Cognizant's Advanced AI Lab, Cognizant is supporting enterprise AI adoption through its AI Innovation Studios in
Cognizant is dedicated to maintaining the highest standards for responsible and ethical AI, focusing on safety, security, privacy, transparency, and inclusion. For additional details on Cognizant's approach to gen AI and the company's commitment to responsible AI, visit here. Cognizant also develops research and insights that help leaders make informed decisions to fuel their companies' success. In partnership with Oxford Economics, Cognizant recently published a study on the economic impact of AI, "New World, New Work," and intends to release further research on AI's impact on productivity, tasks, skills, jobs and occupations.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cognizant Technology Solutions (CTSH) PT Lowered to $47 at TD Cowen
- Tempest Therapeutics (TPST) files for 2.43M share offering by selling stockholders
- Neuphoria confirms acquisition talks with Scancell Holdings
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
StanfordSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share